Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 1
2010 1
2011 5
2012 7
2013 5
2014 14
2015 4
2016 13
2017 8
2018 6
2019 2
2020 4
2021 6
2022 4
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Results by year

Filters applied: . Clear all
Page 1
Inhibition of 2-hydroxyglutarate elicits metabolic reprogramming and mutant IDH1 glioma immunity in mice.
Kadiyala P, Carney SV, Gauss JC, Garcia-Fabiani MB, Haase S, Alghamri MS, Núñez FJ, Liu Y, Yu M, Taher A, Nunez FM, Li D, Edwards MB, Kleer CG, Appelman H, Sun Y, Zhao L, Moon JJ, Schwendeman A, Lowenstein PR, Castro MG. Kadiyala P, et al. J Clin Invest. 2021 Feb 15;131(4):e139542. doi: 10.1172/JCI139542. J Clin Invest. 2021. PMID: 33332283 Free PMC article.
Mutated Chromatin Regulatory Factors as Tumor Drivers in Cancer.
Koschmann C, Nunez FJ, Mendez F, Brosnan-Cashman JA, Meeker AK, Lowenstein PR, Castro MG. Koschmann C, et al. Cancer Res. 2017 Jan 15;77(2):227-233. doi: 10.1158/0008-5472.CAN-16-2301. Epub 2017 Jan 6. Cancer Res. 2017. PMID: 28062403 Free PMC article. Review.
Current Approaches for Glioma Gene Therapy and Virotherapy.
Banerjee K, Núñez FJ, Haase S, McClellan BL, Faisal SM, Carney SV, Yu J, Alghamri MS, Asad AS, Candia AJN, Varela ML, Candolfi M, Lowenstein PR, Castro MG. Banerjee K, et al. Front Mol Neurosci. 2021 Mar 11;14:621831. doi: 10.3389/fnmol.2021.621831. eCollection 2021. Front Mol Neurosci. 2021. PMID: 33790740 Free PMC article. Review.
Single vs. combination immunotherapeutic strategies for glioma.
Chandran M, Candolfi M, Shah D, Mineharu Y, Yadav VN, Koschmann C, Asad AS, Lowenstein PR, Castro MG. Chandran M, et al. Expert Opin Biol Ther. 2017 May;17(5):543-554. doi: 10.1080/14712598.2017.1305353. Epub 2017 Mar 20. Expert Opin Biol Ther. 2017. PMID: 28286975 Free PMC article. Review.
The value of EGFRvIII as the target for glioma vaccines.
Lowenstein PR, Castro MG. Lowenstein PR, et al. Am Soc Clin Oncol Educ Book. 2014:42-50. doi: 10.14694/EdBook_AM.2014.34.42. Am Soc Clin Oncol Educ Book. 2014. PMID: 24857059 Free PMC article. Review.
Overview of current immunotherapeutic strategies for glioma.
Calinescu AA, Kamran N, Baker G, Mineharu Y, Lowenstein PR, Castro MG. Calinescu AA, et al. Immunotherapy. 2015;7(10):1073-104. doi: 10.2217/imt.15.75. Immunotherapy. 2015. PMID: 26598957 Free PMC article. Review.
Mutant ATRX: uncovering a new therapeutic target for glioma.
Haase S, Garcia-Fabiani MB, Carney S, Altshuler D, Núñez FJ, Méndez FM, Núñez F, Lowenstein PR, Castro MG. Haase S, et al. Expert Opin Ther Targets. 2018 Jul;22(7):599-613. doi: 10.1080/14728222.2018.1487953. Epub 2018 Jun 20. Expert Opin Ther Targets. 2018. PMID: 29889582 Free PMC article. Review.
76 results